The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. We specialize in the development and commercialization of orally administered anti-cancer agents for various tumor types. Taiho Oncology has a robust pipeline of small molecule clinical candidates targeting solid tumor and hematological malignancies, with additional candidates in pre-clinical development.